As the country’s apex health regulatory body intensifies its scrutiny of drug manufacturing practices throughout India, it has rolled out fresh guidelines for sampling drugs, cosmetics, and medical devices.
Health Minister Mansukh Mandaviya said that an extensive risk-based analysis is done continuously to ensure the production of quality medicines in the country, and the government and regulators are always alert to ensure that no one dies due to spurious medicines. Get more India News and Business News on Zee Business.
In a massive crackdown against the pharmaceutical companies manufacturing spurious medicines, the govt of India cancelled the licenses of 18 such companies.